4605.7040 Disease And Reports; Clinical Materials Submissions


Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
4605.7040 DISEASE AND REPORTS; CLINICAL MATERIALS SUBMISSIONS.

Cases, suspected cases, carriers, and deaths due to the following diseases and infectious agents shall be reported. When submission of clinical materials is required under this part, submissions shall be made to the Minnesota Department of Health, Public Health Laboratory.

§
A.

Diseases reportable immediately by telephone to the commissioner:

§
(1)

anthrax (Bacillus anthracis). Submit clinical materials;


§
(2)

botulism (Clostridium botulinum);


§
(3)

brucellosis (Brucella spp.). Submit clinical materials;


§
(4)

cholera (Vibrio cholerae). Submit clinical materials;


§
(5)

diphtheria (Corynebacterium diphtheriae). Submit clinical materials;


§
(6)

hemolytic uremic syndrome. Submit clinical materials;


§
(7)

measles (rubeola). Submit clinical materials;


§
(8)

meningococcal disease (Neisseria meningitidis) (all invasive disease). Submit clinical materials;


§
(9)

orthopox virus. Submit clinical materials;


§
(10)

plague (Yersinia pestis). Submit clinical materials;


§
(11)

poliomyelitis. Submit clinical materials;


§
(12)

Q fever (Coxiella burnetii). Submit clinical materials;


§
(13)

rabies (animal and human cases and suspected cases);


§
(14)

rubella and congenital rubella syndrome. Submit clinical materials;


§
(15)

severe acute respiratory syndrome (SARS). Submit clinical materials;


§
(16)

smallpox (variola). Submit clinical materials; and


§
(17)

tularemia (Francisella tularensis). Submit clinical materials.



§
B.

Diseases reportable within one working day:

§
(1)

amebiasis (Entamoeba histolytica/dispar);


§
(2)

anaplasmosis (Anaplasma phagocytophilum);


§
(3)

arboviral disease, including, but not limited to, LaCrosse encephalitis, eastern equine encephalitis, western equine encephalitis, St. Louis encephalitis, and West Nile virus disease;


§
(4)

babesiosis (Babesia spp.);


§
(5)

blastomycosis (Blastomyces dermatitidis);


§
(6)

campylobacteriosis (Campylobacter spp.). Submit clinical materials;


§
(7)

cat scratch disease (infection caused by Bartonella species);


§
(8)

chancroid (Haemophilus ducreyi);


§
(9)

Chlamydia trachomatis infections;


§
(10)

coccidioidomycosis;


§
(11)

cryptosporidiosis (Cryptosporidium spp.). Submit clinical materials;


§
(12)

cyclosporiasis (Cyclospora spp.). Submit clinical materials;


§
(13)

dengue virus infection;


§
(14)

Diphyllobothrium latum infection;


§
(15)

ehrlichiosis (Ehrlichia spp.);


§
(16)

encephalitis (caused by viral agents);


§
(17)

enteric Escherichia coli infection (E. coli O157:H7, other enterohemorrhagic (Shiga toxin-producing) E. coli, enteropathogenic E. coli, enteroinvasive E. coli, and enterotoxigenic E. coli). Submit clinical materials;


§
(18)

Enterobacter sakazakii in infants under one year of age. Submit clinical materials;


§
(19)

giardiasis (Giardia lamblia);


§
(20)

gonorrhea (Neisseria gonorrhoeae infections);


§
(21)

Haemophilus influenzae disease (all invasive disease). Submit clinical materials;


§
(22)

hantavirus infection;


§
(23)

hepatitis (all primary viral types including A, B, C, D, and E);


§
(24)

histoplasmosis (Histoplasma capsulatum);


§
(25)

human immunodeficiency virus (HIV) infection, including acquired immunodeficiency syndrome (AIDS). Submit clinical materials;


§
(26)

influenza (unusual case incidence, critical illness, or laboratory confirmed cases). Submit clinical materials;


§
(27)

Kawasaki disease;


§
(28)

Kingella spp. (invasive only). Submit clinical materials;


§
(29)

legionellosis (Legionella spp.). Submit clinical materials;


§
(30)

leprosy (Hansen's disease) (Mycobacterium leprae);


§
(31)

leptospirosis (Leptospira interrogans);


§
(32)

listeriosis (Listeria monocytogenes). Submit clinical materials;


§
(33)

Lyme disease (Borrelia burgdorferi);


§
(34)

malaria (Plasmodium spp.);


§
(35)

meningitis (caused by viral agents);


§
(36)

mumps;


§
(37)

neonatal sepsis (bacteria isolated from a sterile site, excluding coagulase-negative Staphylococcus) less than seven days after birth. Submit clinical materials;


§
(38)

pertussis (Bordetella pertussis). Submit clinical materials;


§
(39)

psittacosis (Chlamydiophila psittaci);


§
(40)

retrovirus infections;


§
(41)

Reye syndrome;


§
(42)

rheumatic fever (cases meeting the Jones criteria only);


§
(43)

Rocky Mountain spotted fever (Rickettsia rickettsii, R. canada);


§
(44)

salmonellosis, including typhoid (Salmonella spp.). Submit clinical materials;


§
(45)

shigellosis (Shigella spp.). Submit clinical materials;


§
(46)

Staphylococcus aureus (only vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-resistant Staphylococcus aureus (VRSA), and death or critical illness due to community-associated Staphylococcus aureus in a previously healthy individual). Submit clinical materials;


§
(47)

streptococcal disease (all invasive disease caused by Groups A and B streptococci and S. pneumoniae). Submit clinical materials;


§
(48)

syphilis (Treponema pallidum);


§
(49)

tetanus (Clostridium tetani);


§
(50)

toxic shock syndrome. Submit clinical materials;


§
(51)

toxoplasmosis (Toxoplasma gondii);


§
(52)

transmissible spongiform encephalopathy;


§
(53)

trichinosis (Trichinella spiralis);


§
(54)

tuberculosis (Mycobacterium tuberculosis complex) (pulmonary or extrapulmonary sites of disease, including laboratory confirmed or clinically diagnosed disease). Latent tuberculosis infection is not reportable. Submit clinical materials;


§
(55)

typhus (Rickettsia spp.);


§
(56)

varicella zoster disease:

§
(a)

primary (chickenpox): unusual case incidence, critical illness, or laboratory-confirmed cases. Submit clinical materials; and


§
(b)

recurrent (shingles): unusual case incidence or critical illness. Submit clinical materials;



§
(57)

varicella zoster disease in addition to reportable disease under subitem (56), effective upon the commissioner's determination that the disease is reportable under part 4605.7042;


§
(58)

Vibrio spp. Submit clinical materials;


§
(59)

yellow fever; and


§
(60)

yersiniosis, enteric (Yersinia spp.). Submit clinical materials.